Home/PeptiDream/Toru Yamaguchi
TY

Toru Yamaguchi

Former Executive Officer / Key Scientist

PeptiDream

PeptiDream Pipeline

DrugIndicationPhase
PD-1/IL-2Solid TumorsPhase 1/2
PPS-001Undisclosed OncologyPreclinical
177Lu-PNT6555 (w/ Novartis)Small Cell Lung Cancer (DLL3+)Phase 1